Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
E

Failure to Document Rationale for Declining Gradual Dose Reductions of Psychotropic Medications

Butte, Montana Survey Completed on 05-19-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that gradual dose reductions (GDR) for psychotropic medications were attempted or that adequate, patient-specific rationales were documented when GDRs were not performed for three residents. For one resident with dementia, the pharmacist recommended a GDR for Seroquel, but the prescriber declined with only a general statement that the patient was stable, without further clinical justification. Another resident was on Sertraline, and the prescriber responded to the pharmacist's GDR recommendation with a vague comment that "things look good," lacking any specific rationale for maintaining the current dose. A third resident was receiving Duloxetine, Trazodone, and Provigil, and the prescriber declined the pharmacist's GDR recommendations for all three medications without documenting patient-specific reasons for not attempting dose reductions. Additionally, a staff member interviewed was unaware of the documentation requirements for supporting or declining GDRs and was behind on addressing pharmacy recommendations due to personal issues. The facility's policy requires that residents on psychotropic drugs receive GDRs and behavioral interventions unless clinically contraindicated, with clinical rationales documented when GDRs are not attempted. However, the medical records reviewed did not contain adequate documentation to support the continued use of psychotropic medications at the current doses or to explain why GDRs were clinically contraindicated.

An unhandled error has occurred. Reload 🗙